🇺🇸

US SEC Filing Intelligence

Daily AI-powered analysis of SEC EDGAR filings, FDA approvals, and US regulatory disclosures. Investment signals, risk flags, and sector themes for US markets.

· daily

Biotech Small-Cap Approvals — October 16, 2026

This digest covers a single-day-window stream of three FDA actions dated October 9 to 13, 2026, with no NMEs classified by mix (0 NME, 0 biosimilar, 0 label expansion in the mix tally) and three 'Other' designations; however, the individual analyses identify PRITELIVIR (AiCuris Anti-Infective Cures AG) as an NME approval under Priority Review, making it the highest-conviction event in the set. Pritelivir, branded HOVILPR, carries an 8/10 signal strength and materiality, and its Priority Review designation signals FDA recognition of significant unmet need in its indication. The remaining two actions are a biosimilar-designated approval of donepezil hydrochloride from Strides Pharma International (neutral, 5/10) and a label expansion for iopamidol (ISOVUE READI) from Bracco (bullish, 5/10). No dominant therapeutic area cluster is evident from the available data, as the three approvals span antiviral, neurology, and contrast imaging categories. The key watch item is the classification inconsistency: the Donepezil entry is labeled biosimilar in its summary yet the approval type is recorded as FALLBACK, and commercial metrics across all three entries are NOT_DISCLOSED, limiting quantitative conviction.

3 total filings
· daily

NME Blockbuster Approvals — October 16, 2026

This digest covers a single FDA approval event in the October 16, 2026 reporting window, which is the sole entry in the NME Blockbuster Approvals stream. The approval mix is 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other action, so no first-in-class molecular entity or biosimilar entrant is captured in this period. The one event is PRITELIVIR (HOVILPR), approved for AICURIS Anti-Infective Cures AG under a Priority Review designation, which the source classifies as an NME approval with a fallback approval-type tag. The highest-conviction signal is bullish (strength 8/10, materiality 8/10) for AICURIS, given that Priority Review status signals FDA recognition of significant benefit, though peak sales, exclusivity period, pricing power, and market position are all NOT_DISCLOSED and cannot be quantified from available data. No therapeutic area clustering is observable from a single approval. The key watch item is the classification ambiguity (NME label versus fallback approval type), which should be verified against the FDA action letter before the position is sized, along with the absence of any disclosed commercial parameters.

1 total filings
· daily

Big Pharma Approvals — October 16, 2026

This digest covers a single FDA approval event for the period October 16, 2026, a label expansion for baricitinib (OLUMIANT) sponsored by Eli Lilly and Co. The approval mix is 0 NMEs, 0 biosimilars, 0 label expansions by the classification provided (the one approval is categorized as 'Other' with a FALLBACK approval type), so no new molecular entity or biosimilar signal is present this period. The single event carries a bullish signal (strength 5/10, materiality 5/10), reflecting incremental indication-driven revenue potential for an established oral JAK inhibitor rather than a new franchise. No therapeutic area clustering can be drawn from a single approval. The key watch item is that commercial parameters (peak sales, exclusivity, pricing power, market position) are not disclosed in the source data, so the magnitude of the expansion cannot be sized from this digest alone.

1 total filings
· daily

New Drug Approvals (Original) — October 16, 2026

This digest covers a single-day window (October 16, 2026) and three original approvals in the New Drug Approvals stream, but the approvals themselves are dated October 9 and October 13, 2026. The mix is 0 NMEs, 0 biosimilars, 0 label expansions, and 3 other, so the classification data does not produce a conventional NME/biosimilar/expansion breakdown. Of the three, PRITELIVIX-equivalent signal aside, the highest-conviction item is PRITELIVIR (HOVILPR) from AiCuris Anti-Infective Cures AG, which the source data describes as an NME approval under Priority Review with a bullish signal at strength 8/10. IOPAMIDOL (ISOVUE READI) from Bracco received a bullish label expansion signal at 5/10, while DONEPEZIL HYDROCHLORIDE from Strides Pharma International carries a neutral signal at 5/10 despite being described as a biosimilar approval, an internal inconsistency that should be verified. No dominant therapeutic area cluster is identifiable from a set this small, and commercial metrics (peak sales, exclusivity, pricing power, market position) are NOT_DISCLOSED across all three approvals. The key watch item is the approval-type classification conflict for DONEPEZIL, which, if it is in fact a biosimilar, would carry originator-side erosion implications for Eisai's Aricept franchise; that linkage is inferred rather than sourced here.

3 total filings
· daily

Federal Construction & Infrastructure Contracts — October 16, 2026

This digest covers a single federal construction award totaling $35,935,733 in obligation, made by the Department of Veterans Affairs (civilian, zero defense-related awards) to CARIBE TECNO CRL for Phase 5 parking garage construction at VAMC San Juan. The base-plus-options value is $63,001,943, so obligation represents roughly 57% of ceiling, and $13,861,385 (about 39% of obligated value) had been outlaid as of the data date. The dominant theme is civilian VA facilities construction under a total small business set-aside, a policy-driven award rather than a competitive win. The highest-conviction read is that the award is operationally visible but not investable, since the recipient is privately held with no ticker or financial disclosures. The key watch item is the 2026-10-14 contract end date, which falls just before this digest's period and makes option exercise, schedule adherence, and outlay progress the critical near-term monitoring points.

1 total filings
· daily

DOD Defense Contracts Intelligence — October 16, 2026

This digest covers a single DOD-stream contract record totaling $32,680,359 in obligations, with 0 of 1 records classified as defense-related under the stream's criteria despite the Department of the Army as awarding agency. The dominant theme is Army Corps of Engineers (ENDIST Kansas City) funding for Superfund remediation, specifically the WACC Superfund OU1 Remedial Action at Ridgewood, NY, awarded to Sevenson Environmental Services, Inc. on 2024-06-18. The highest-conviction read is structural rather than directional: the Cost Plus Fixed Fee pricing shifts most cost-overrun risk to the government, which lowers contractor downside, though the fixed fee caps profit upside. The key watch item is that no outlays had been reported ($0 disbursed), and the data does not establish whether Sevenson is publicly traded, so investment relevance cannot be confirmed from this record alone. Average signal strength is 4.0/10 with a materiality score of 3/10, so this single record is low-materiality for portfolio decisions.

1 total filings
· daily

DHS Homeland Security Contracts — October 16, 2026

Three DHS awards totaling $68,681,923 in obligations were analyzed for the October 16, 2026 period, with zero defense-related records and all three classified as civilian homeland security work. The largest award, GOLDEN SVCS, LLC's $35,454,081 Armed Guard II delivery order from DHS Federal Protective Service (2024-09-01 to 2027-08-31), carries the highest materiality but its public-company exposure cannot be confirmed from the data. LMD AGENCY, INC.'s $20,000,000 CBP national media campaign BPA call (awarded 2026-09-20) has $0 outlayed to date, so its revenue pace is unproven. LEIDOS, INC.'s $13,227,842 TSA delivery order is a closed-out 2017 award with only $57 outlayed, offering little current signal. The highest-conviction takeaway is that the DHS physical-security stream is durable but low-materiality for listed investors; the primary watch item is whether obligations from the GOLDEN and LMD awards convert into actual outlays, given that $13.2M of GOLDEN's ceiling remains unobligated and LMD has recorded no outlays.

3 total filings
· daily

VA Healthcare & Services Contracts — October 16, 2026

Three VA construction and healthcare-facility awards totaling $68,397,022 were analyzed, with 0 of 3 defense-related, so the entire digest falls under the civilian (Department of Veterans Affairs) context. The dominant theme is VA facility construction under set-asides: CARIBE TECNO CRL's $35,935,733 parking garage at VAMC San Juan (the largest obligation, 52.5% of the aggregate), TROOP CONTRACTING INC's $17,407,128 sterile processing expansion at the Captain James A. Lovell FHCC, and SENATE BUILDERS & CONSTRUCTION MANAGERS, INC.'s $15,054,159 administration building at the Wilmington VA Medical Center. All three are rated neutral with strength 3/10 and materiality 2/10, and none of the recipients is identified as publicly traded, so direct equity exposure cannot be established from this data. The highest-conviction signal is the steady flow of VA facility construction spending reaching SDVOSB and small-business contractors, though this is a demand indicator rather than a tradable thesis. The key watch item is outlay progression: CARIBE TECNO's $13,861,385 outlayed against its 2026-10-14 end date and the $0 outlayed on the two later-stage awards will determine whether these projects are executing on schedule.

3 total filings
· daily

New Federal Contractors — October 16, 2026

The 27 new federal contract awards in this period total $602,147,093 in obligations, with only one defense-related award (the GSA-routed Sigma Defense Systems LLC Joint AISR integration and sustainment order at $23,872,699) and the remaining 26 split across civilian agencies including HHS, VA, DHS, Treasury, USDA, NASA, and GSA. No single award is individually material to a large public parent based on the data provided, and every record is rated neutral, so the investment signal is one of breadth rather than concentration. The most meaningful individual awards are the Whitestone Group HHS security guard order ($51,818,963), the Caribe Tecno VA parking garage construction ($35,935,733), and the GOLDEN SVCS DHS Armed Guard II order ($35,454,081), but none of the recipients is shown to be publicly traded, so direct equity exposure cannot be confirmed. The dominant theme is recurring civilian services and IT labor work, with little evidence of new defense growth in this window. The main watch item is that most records lack outlay progress or recipient ownership data, so materiality and investability cannot be verified for the majority of awards.

27 total filings
· daily

Significant Contract Modifications ($10M+) — October 16, 2026

The 27 significant contract modifications in this period total $602,147,093 in obligations, with only one defense-related award (Sigma Defense Systems LLC, $23,872,699 via GSA on behalf of ACC) and the remainder civilian, led by HHS, DHS, VA, GSA, and NASA. The dominant theme is labor-based civilian services and IT support (security guards, application development, data analytics, engineering support) rather than defense platform spending. Most individual awards are small relative to public-company revenue bases, and most recipients are private, nonprofit, or lack disclosed parent listings, so direct investability is limited across the set. The highest-materiality items are Whitestone Group ($51.8M, HHS security services), StoneX Financial ($32.7M, U.S. Mint silver delivery with $0 outlayed and an 8-day performance window), and Sevenson Environmental Services ($32.7M, Army Superfund remediation), though none establish a clear public-equity catalyst. The key watch item is the large share of obligations with $0 or unexplained outlays (including a negative $-1,352 outlay on the USPTO HALVIK award), which limits confidence in realized revenue until billing data confirms execution.

27 total filings
· daily

Contract Deobligations Alert — October 16, 2026

The 27 contracts in this deobligations-alert stream total $602,147,093 in obligations, with only one defense-related award (Sigma Defense Systems LLC, $23,872,699 via GSA on behalf of defense customers) and the remainder civilian, led by DHS, HHS, VA, GSA, and NASA. No contract in the set carries a clear bullish or bearish signal; all 27 are rated neutral at an average strength of 3.0/10, reflecting that most recipients are private or nonprofit entities with no disclosed public parent. The highest-materiality items are Whitestone Group ($51.8M, HHS security guard services, roughly 90% outlayed), Caribe Tecno ($35.9M VA parking structure), and GOLDEN SVCS ($35.5M DHS Armed Guard II), though none is linked to an identifiable investable equity. The clearest watch items are contracts with stalled or unexplained outlay data, notably Steampunk and Leidos closeout anomalies, HALVIK's negative $-1,352 outlay, and Deloitte's $0 outlay on a $30.5M delivery order, plus several awards whose current end dates have already passed (ECS Federal, Booz Allen, Leidos, Data Computer Corp).

27 total filings
· daily

Contract Option Exercises — October 16, 2026

The 27 option-exercise and delivery-order records in this period total $602,147,093 in obligations, with only 1 defense-related award (GSA-routed Sigma Defense Systems LLC, $23,872,699) and the remainder civilian, led by HHS, DHS, VA, USDA, NASA and GSA. Every record was classified neutral (average signal strength 3.0/10), so the batch offers no directional bullish or bearish call; its value lies in the contract-level execution and visibility detail. The largest awards, The Whitestone Group ($51,818,963, HHS security guard services) and Caribe Tecno CRL ($35,935,733, VA parking garage), are service or construction work with no stated public-market parent, limiting investability. The most useful execution signal is the high outlay ratio on Booz Allen-era and Steampunk-type IT work, while the main watch item is the large share of records showing $0 or near-zero outlays (StoneX, Sevenson, Sigma, LMD, Senate Builders), which leaves realized revenue unverified and makes near-term earnings contribution uncertain.

27 total filings
· daily

Federal Professional Services Contracts — October 16, 2026

Six federal professional services delivery orders and BPA calls totaling $119,527,626 in obligations were analyzed, with only one (SIGMA DEFENSE SYSTEMS LLC, $23,872,699, routed via GSA for Joint AISR sustainment) defense-related; the remaining five are civilian (DOT $41.3M across WERIS and CSSI, NASA $23.8M via COLSA, HHS/AHRQ $17.4M via Westat, DHS/TSA $13.2M via Leidos). The dominant theme is civilian transportation and science-support services spending, not defense, and every contract carries a neutral signal with an average strength of 3.0/10. The highest-materiality award is WERIS, INC's $28,352,140 FHWA order (62% outlaid, performance through 2027-08-17), but its investment relevance depends on public-company status the data does not establish. The principal watch item is the thin outlay record: Leidos shows only $57 outlaid against $13.2M on a closed-out 2017 order, and SIGMA shows $0 outlaid on a $23.9M award, so realized revenue cannot yet be confirmed for these positions. No contract in this set supports a directional bullish or bearish call on a listed equity.

6 total filings
· daily

Federal IT & Cybersecurity Contracts — October 16, 2026

The nine federal IT and cybersecurity awards in this period total $180,441,518 in obligations across the Department of Commerce, GSA, Education, SSA, HHS, and USDA, with zero defense-related awards, so the entire set is civilian and this stream offers no direct DOD exposure signal. The dominant theme is civilian IT modernization and application development/sustainment labor, led by HALVIK LLC's $31,964,411 USPTO Patent Center delivery order and Deloitte Consulting LLP's $30,525,469 GSA capacity-building award. The highest-conviction signal is the FEDTEC LLC SSA BPA call (up to $103,192,848 ceiling, $6,052,979 outlayed), though most recipients are private or not publicly traded, so direct equity implications are limited. The key watch item is execution and continuity risk: several awards are past or near their stated end dates (ECS Federal's 2020 end, Booz Allen's 2023 end, HHS APPS's 2026-06-16 end), and the HALVIK record shows an unexplained negative outlay of $-1,352.

9 total filings
· daily

NASA & Space Contracts Intelligence — October 16, 2026

Three NASA-related awards totaling $42,291,439 in total obligation were reviewed for the period October 16, 2026, with zero defense-related contracts, so the entire set is civilian space R&D. All three awards run to Caltech (California Institute of Technology), which operates JPL under NASA's Management Office: a $15,406,186 ROSES research delivery order, a $13,939,429 Dragonfly flight hardware delivery order, and a $12,945,824 ExoMars Trace Gas Orbiter Phase A order. The dominant theme is sustained NASA funding for JPL-managed planetary and earth science, with multi-year periods of performance running to 2027-2028. Because the recipient is a nonprofit, tax-exempt institution, none of the awards creates direct public-equity exposure, and the highest-conviction read is therefore about agency budget durability rather than a tradable stock. The key watch item is option exercise and funding actions, since the Caltech ROSES award has roughly $8.5M of unobligated base-plus-options value and only about 4.6% outlayed.

3 total filings
· daily

All HHS Contracts — October 16, 2026

Four HHS contracts totaling $99,597,960 in obligations were analyzed for the single-day period of October 16, 2026, with zero defense-related awards, so the entire set is civilian and concentrated in health-agency services and IT. The Whitestone Group, Inc. (HHS Program Support Center, $51,818,963, security guard services) accounts for about 52% of the total and is the highest-materiality award, though the data does not establish whether the company is publicly traded. The remaining three awards, Westat, Inc. ($17,374,312, AHRQ patient-experience research), Data Computer Corporation of America ($16,222,256, CMS APPS payment system), and Booz Allen Hamilton Inc ($14,182,428, CDC SEDAV analytics), are each low-materiality and all carry neutral signals with strength 3/10. The most actionable item is Booz Allen Hamilton's SEDAV call, whose current period ended 2023-09-26 and whose potential extension to 2024-04-26 has already lapsed, so its status is unverified. The key watch item is the Whitestone Group's roughly $6M of unexercised option value and its end date of 2026-12-12, given that the data does not disclose public-company status needed to make the award investable.

4 total filings
· daily

All DOD Contracts — October 16, 2026

This digest covers a single DOD contract record for the period October 16, 2026, totaling $32,680,359 in obligations, with 0 of 1 awards classified as defense-related under the stream definition used here. The dominant theme is Army Corps of Engineers (ENDIST Kansas City) funding for environmental remediation, specifically WACC Superfund OU1 Remedial Action at Ridgewood, NY. The highest-conviction observation is the pricing structure: the Cost Plus Fixed Fee arrangement shifts most cost-overrun risk to the government, which lowers contractor downside. The primary watch item is that $0 has been outlaid to date, so realized revenue depends on disbursement over the performance period ending April 9, 2027, and the publicly traded status of the recipient is not established by the data. Average signal strength is 4.0/10 and materiality is low (3/10), so this record should be treated as a minor data point rather than a sector-moving award.

1 total filings
· daily

High-Value Federal Grants ($5M+) — October 16, 2026

The 27 high-value federal grant and contract records in this October 16, 2026 digest total $602,147,093 in obligations, of which only one (the Sigma Defense Systems LLC GSA-routed Joint AISR sustainment order at $23,872,699) is defense-related, so the stream is overwhelmingly civilian (HHS, DHS, VA, USDA, NASA, DOT, Treasury, Commerce). The dominant theme is civilian services and IT modernization rather than defense procurement, with labor-based security guard, IT application, and consulting awards prominent. No signal in this set rises above neutral (all 27 are rated neutral, average strength 3.0/10), and most recipients are privately held or lack disclosed public parents, which limits direct investability. The highest-materiality items are the Whitestone Group ($51,818,963, HHS security guard services) and CARIBE TECNO ($35,935,733, VA parking garage), though neither is tied to a verifiable public ticker. The key watch item is the wide gap between obligated and outlayed amounts on several large awards, including $0 outlayed on the StoneX Financial $32,735,314 Mint silver order and the Sevenson Environmental $32,680,359 Superfund remediation, which will only become a meaningful revenue signal once billing data appears.

27 total filings
· daily

General Federal Contracts — October 16, 2026

Across 27 federal contract records totaling $602,147,093 in obligations over the period, only 1 is defense-related (the Sigma Defense Systems LLC GSA-routed Joint AISR sustainment award at $23,872,699), so the stream is overwhelmingly civilian, led by HHS, DHS, VA, NASA, and USDA. The dominant theme is services-based, labor-hour and firm-fixed-price work in IT modernization, security guard services, facilities construction, and research support, with several awards tied to a small number of civilian agencies. The highest-materiality single award is The Whitestone Group's $51,818,963 HHS security guard order, though its public-market relevance is undetermined. Every record is tagged neutral with an average signal strength of 3.0/10, and most recipients are private, so there is little direct equity signal in this batch. The key watch item is outlay progression: several large awards (Whitestone, GOLDEN SVCS, STEAMPUNK, CSSI) show high burn or unexplained figures, and NASA JPL awards to Caltech are nonprofit and not investable.

27 total filings
· daily

All NASA Contracts — October 16, 2026

Across four NASA contract records totaling $66,071,995 in obligations, none are defense-related; all four are civilian space and science awards. The dominant theme is NASA funding flowing to the Jet Propulsion Laboratory management office via Caltech (three of four awards, about $42.3M combined obligation) plus one NASA shared services award to COLSA Corp ($23,780,556). The highest-conviction read is that NASA's JPL-managed planetary and science R&D (Dragonfly, ExoMars TGO, ROSES) carries multi-year period-of-performance commitments through 2027-2028, supporting sustained civilian funding. Caltech is a nonprofit with no public equity exposure, so the investable signal is limited to COLSA Corp and to the broader NASA space-R&D funding trend. The key watch item is outlay progression on COLSA's NTSS Year 3 task order (only $17.2M of $23.8M spent) and option exercise timing across the Caltech awards; the sample is a single day window and cannot establish a budget trend.

4 total filings